These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17195196)

  • 21. Febuxostat--treatment for hyperuricemia and gout?
    Moreland LW
    N Engl J Med; 2005 Dec; 353(23):2505-7. PubMed ID: 16339099
    [No Abstract]   [Full Text] [Related]  

  • 22. [Familial gout and nephropathy in a young woman. Report of one case].
    Badilla A; Rojas C
    Rev Med Chil; 2001 Jun; 129(6):666-70. PubMed ID: 11510209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tophaceous gout causing stenosis of T11-T12].
    Rivero-Garvía M; Rodríguez Boto G; Gutiérrez González R; Martínez A
    Med Clin (Barc); 2008 Apr; 130(12):479. PubMed ID: 18405510
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical image: Dual-energy computed tomographic molecular imaging of gout.
    Johnson TR; Weckbach S; Kellner H; Reiser MF; Becker CR
    Arthritis Rheum; 2007 Aug; 56(8):2809. PubMed ID: 17665437
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.
    Perez-Ruiz F; Calabozo M; Pijoan JI; Herrero-Beites AM; Ruibal A
    Arthritis Rheum; 2002 Aug; 47(4):356-60. PubMed ID: 12209479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A clinical picture of chronic polyarticular tophaceous gout.
    Salvi AE; Metelli GP; Domeneghini E; Cantalamessa A
    Rheumatol Int; 2010 Apr; 30(6):829-30. PubMed ID: 20012865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An unexpected manifestation of gout.
    Gamala M; Jacobs JWG; Heggelman BGF; Klaasen R
    Rheumatology (Oxford); 2020 Apr; 59(4):810. PubMed ID: 31549169
    [No Abstract]   [Full Text] [Related]  

  • 28. Gout management: let's get it right this time.
    Sundy JS
    Arthritis Rheum; 2008 Nov; 59(11):1535-7. PubMed ID: 18975368
    [No Abstract]   [Full Text] [Related]  

  • 29. A new standard of care? Studies on febuxostat in the management of hyperuricemia with and without gout.
    Kamatani N; Hosoya T
    J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S11-2. PubMed ID: 21654264
    [No Abstract]   [Full Text] [Related]  

  • 30. Interleukin-1 inhibition by anakinra in refractory chronic tophaceous gout.
    Tran AP; Edelman J
    Int J Rheum Dis; 2011 Aug; 14(3):e33-7. PubMed ID: 21816011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recognition and management of gout and hyperuricemia.
    Yennie RH
    JAAPA; 2003 Mar; 16(3):21-4, 27-8, 31. PubMed ID: 14968523
    [No Abstract]   [Full Text] [Related]  

  • 32. A phase 3, multicenter, randomized, allopurinol-controlled study assessing the safety and efficacy of oral febuxostat in Chinese gout patients with hyperuricemia.
    Xu S; Liu X; Ming J; Chen S; Wang Y; Liu X; Liu H; Peng Y; Wang J; Lin J; Ji H; Liu B; Lu Y; Liu P; Zhang Y; Ji Q
    Int J Rheum Dis; 2015 Jul; 18(6):669-78. PubMed ID: 26013187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal-associated arthritis in the elderly.
    Wise CM
    Clin Geriatr Med; 2005 Aug; 21(3):491-511, v-vi. PubMed ID: 15911203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors associated with recurrent hospital admissions for gout: a case-control study.
    Hutton I; Gamble G; Gow P; Dalbeth N
    J Clin Rheumatol; 2009 Sep; 15(6):271-4. PubMed ID: 19734730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between serum urate and plasma oxypurinol in the management of gout: determination of minimum plasma oxypurinol concentration to achieve a target serum urate level.
    Stamp LK; Barclay ML; O'Donnell JL; Zhang M; Drake J; Frampton C; Chapman PT
    Clin Pharmacol Ther; 2011 Sep; 90(3):392-8. PubMed ID: 21796116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How PCP education can impact gout management: the gout essentials.
    Weaver AL; Cheh MA; Kennison RH
    J Clin Rheumatol; 2008 Oct; 14(5 Suppl):S42-6. PubMed ID: 18830090
    [No Abstract]   [Full Text] [Related]  

  • 37. Febuxostat for the treatment of hyperuricaemia in people with gout: a single technology appraisal.
    Stevenson M; Pandor A
    Health Technol Assess; 2009 Oct; 13 Suppl 3():37-42. PubMed ID: 19846027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myeloperoxidase and oxidation of uric acid in gout: implications for the clinical consequences of hyperuricaemia.
    Stamp LK; Turner R; Khalilova IS; Zhang M; Drake J; Forbes LV; Kettle AJ
    Rheumatology (Oxford); 2014 Nov; 53(11):1958-65. PubMed ID: 24899662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of gout.
    Cohen MG
    Intern Med J; 2011 Jan; 41(1a):70-1. PubMed ID: 21265967
    [No Abstract]   [Full Text] [Related]  

  • 40. Case 9: initiation of urate-lowering therapy for advanced gout complicated by chronic renal insufficiency.
    Edwards NL
    Am J Med; 2006 Nov; 119(11 Suppl 1):S29-31. PubMed ID: 17059911
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.